Genomic analysis of Chromobacterium haemolyticum: insights into the species resistome, virulence determinants and genome plasticity

Mol Genet Genomics. 2020 Jul;295(4):1001-1012. doi: 10.1007/s00438-020-01676-8. Epub 2020 Apr 19.

Abstract

The increasing number of Chromobacterium haemolyticum human infection reports, especially in tropical regions and connected with environmental sources, resulted in an urge to better describe this species. This study aimed to characterize the C. haemolyticum resistome, virulence determinants and genetic platforms related with genome plasticity. A comparative genomic analysis was conducted between clinical C. haemolyticum genomes publicly available and the genome of an environmental isolate obtained in this study. The pangenome of C. haemolyticum was calculated and a total of 3378 core genes were predicted in its core genome, corresponding to 51.7% of the pangenome. Genetic determinants putatively encoding resistance to beta-lactams, fosfomycin, aminoglycosides and trimethoprim were predicted in all genomes, possibly constituting the intrinsic resistome of this species. In terms of resistance to beta-lactams, 4 genes were predicted encoding beta-lactamases of classes A, C and D. Moreover, the analysis of Chromobacterium genomes and C. haemolyticum environmental isolates reinforced the role of this genus as progenitor of the blaKPC gene. Putative virulence factors (VFs) were predicted in all genomes, related to adherence, toxins production, colonization and cell invasion. Secretion systems, including type III, were detected. A significant number of transposases and genomic islands were predicted in C. haemolyticum, in some cases above the average reported for Gram-negative bacterial genomes. We conclude that C. haemolyticum strains, including those of environmental origin, present a noteworthy collection of antibiotic resistance genes and VFs. Furthermore, sequences related to gene mobility and genome plasticity suggest high adaptability potential and a possible role as disseminator of antibiotic resistance.

Keywords: Antibiotic resistance; Beta-lactamases; Chromobacterium haemolyticum; Environment; KPC; Opportunistic pathogen; Whole-genome sequencing.

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections / drug therapy
  • Bacterial Infections / genetics*
  • Bacterial Infections / microbiology
  • Chromobacterium / classification
  • Chromobacterium / drug effects
  • Chromobacterium / genetics*
  • Chromobacterium / pathogenicity
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Genome, Bacterial / drug effects
  • Genome, Bacterial / genetics
  • Genomics
  • Humans
  • Microbial Sensitivity Tests
  • Phylogeny*
  • Virulence / genetics

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Chromobacterium haemolyticum